Pending EO 12866 Regulatory Review
RIN: 0910-AI37 View EO 12866 Meetings | Received Date: 06/13/2022 |
Title: Investigational New Drug Application Annual Reporting | |
Agency/Subagency: HHS / FDA | Stage: Proposed Rule |
Legal Deadline: None | Economically Significant: No |
International Impacts: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
Pandemic Response: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |